Recombinetics received a $100,000 grant from Regenerative Medicine Minnesota to advance development of an inducible immunodeficient swine to help fill a significant unmet need in biomedicine.
The Company appreciates the legislature’s dedication to supporting innovation by the regenerative medicine industry in the state of Minnesota.
